Clinical Trial Update: HAI Abraxane With Gemcitabine and Bevacizumab [Phase 1]

View source ↗

Summary

Phase 1 trial of hepatic arterial infusion with Abraxane (nab-paclitaxel) plus gemcitabine and bevacizumab in patients with advanced cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 1 | Status: COMPLETED